Episode 25014
Breaking Barriers in Brain Cancer... Dr. Thomas Chen, Founder and CEO, NeOnc Technologies
BioTech Nation ... with Dr. Moira Gunn · Moira Gunn
April 9, 202524m 39s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week on BioTech Nation, Dr. Thomas Chen, Director of Neuro-Oncology at USC and Founder of NeOnc Technologies, shares treating glioblastoma by delivering a drug directly to the brain through nasal inhalation changes the drug delivery game, bypassing the blood-brain barrier. This technique is achieving results in clinical trials.
Topics
brain cancerglioblastomabrain tumor treatmentblood-brain barriernasal drug deliveryNeOnc TechnologiesDr. Thomas ChenUSC Neuro-OncologyPOH compoundperillyl alcoholclinical trialsbrain cancer researchinnovative cancer treatmenttargeted drug deliveryphase 2 clinical trialIDH1 mutationneuro-oncologynew cancer therapiesglioblastoma survivalbrain cancer breakthroughBioTech NationMoira Gunncancer treatment innovationFDA-approved clinical trialsoncology advancementstumor reductionnasal brain delivery